EMA Authorised: Nityr (nitisinone) — Cycle Pharmaceuticals (Europe) Ltd

View source ↗

Summary

Nityr (nitisinone) has been authorised in Europe for treatment of tyrosinemias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tyrosinemia
• Tyrosinemia Type

Drugs mentioned

• NITYR (Nitisinone)

Snippet

Status: Authorised. Therapeutic area: Tyrosinemias. MAH: Cycle Pharmaceuticals (Europe) Ltd. Decision date: 04/05/2023